Michal Droppa

632 total citations
38 papers, 426 citations indexed

About

Michal Droppa is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Michal Droppa has authored 38 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 10 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Michal Droppa's work include Cardiac Valve Diseases and Treatments (13 papers), Antiplatelet Therapy and Cardiovascular Diseases (13 papers) and Acute Myocardial Infarction Research (11 papers). Michal Droppa is often cited by papers focused on Cardiac Valve Diseases and Treatments (13 papers), Antiplatelet Therapy and Cardiovascular Diseases (13 papers) and Acute Myocardial Infarction Research (11 papers). Michal Droppa collaborates with scholars based in Germany, Netherlands and United States. Michal Droppa's co-authors include Meinrad Gawaz, Tobias Geisler, Dominik Rath, Karin Müller, Oliver Borst, Peter Seizer, Fabian Stimpfle, Athanasios Karathanos, Matthias Schwab and Harald F. Langer and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Atherosclerosis.

In The Last Decade

Michal Droppa

36 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michal Droppa Germany 13 303 134 66 49 43 38 426
Stefano Lucreziotti Italy 14 313 1.0× 142 1.1× 54 0.8× 33 0.7× 80 1.9× 37 551
Antonella Galeone Italy 13 280 0.9× 250 1.9× 65 1.0× 36 0.7× 67 1.6× 42 486
Aslı Tanındı Türkiye 11 310 1.0× 108 0.8× 75 1.1× 19 0.4× 62 1.4× 28 481
Jae Youn Moon South Korea 15 396 1.3× 271 2.0× 34 0.5× 64 1.3× 72 1.7× 44 527
Ángel López‐Cuenca Spain 10 251 0.8× 60 0.4× 40 0.6× 42 0.9× 22 0.5× 29 371
Tuomo Ilva Finland 12 405 1.3× 87 0.6× 61 0.9× 17 0.3× 31 0.7× 14 542
Dilek Çiçek Türkiye 11 399 1.3× 148 1.1× 36 0.5× 29 0.6× 88 2.0× 36 531
Thibaut Petroni France 8 282 0.9× 209 1.6× 52 0.8× 63 1.3× 24 0.6× 10 527
İmran Önür Türkiye 13 308 1.0× 114 0.9× 115 1.7× 34 0.7× 29 0.7× 27 433
Selime Ayaz Türkiye 12 269 0.9× 154 1.1× 69 1.0× 81 1.7× 66 1.5× 29 505

Countries citing papers authored by Michal Droppa

Since Specialization
Citations

This map shows the geographic impact of Michal Droppa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Droppa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Droppa more than expected).

Fields of papers citing papers by Michal Droppa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Droppa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Droppa. The network helps show where Michal Droppa may publish in the future.

Co-authorship network of co-authors of Michal Droppa

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Droppa. A scholar is included among the top collaborators of Michal Droppa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Droppa. Michal Droppa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zdanytė, Monika, Jüergen Schreieck, Dominik Rath, et al.. (2025). Pre-interventional transesophageal echocardiography as a reliable predictor of residual shunt following patent foramen ovale closure. Clinical Research in Cardiology. 115(3). 484–494.
2.
Rohlfing, Anne‐Katrin, Michal Droppa, Malte N. Bongers, et al.. (2025). Reduced Platelet Aggregation and Plasma Cytokine Levels Mitigate Progressive Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Journal of Inflammation Research. Volume 18. 11385–11400. 1 indexed citations
3.
Droppa, Michal, et al.. (2025). Impact of Mitral Valve Transcatheter Edge-To-Edge Repair on Haemodynamic Parameters in Cardiogenic Shock. ESC Heart Failure. 12(4). 3173–3178. 1 indexed citations
4.
Droppa, Michal & Tobias Geisler. (2024). Optimal Antithrombotic Strategies in Cardiogenic Shock. Journal of Clinical Medicine. 13(1). 277–277. 3 indexed citations
5.
Schreieck, Jüergen, et al.. (2023). Pacemaker Lead Entanglement during Interventional PFO Occlusion: Salvage Using a Sizing Balloon. SHILAP Revista de lepidopterología. 2023. 1–4.
6.
Rudolph, Tanja K., Michal Droppa, Jan Baan, et al.. (2023). Modifiable risk factors for permanent pacemaker after transcatheter aortic valve implantation: CONDUCT registry. Open Heart. 10(1). e002191–e002191. 6 indexed citations
7.
Schaeffeler, Elke, Stefan Winter, Monika Zdanytė, et al.. (2021). C5 Variant rs10985126 is Associated with Mortality in Patients with Symptomatic Coronary Artery Disease. Pharmacogenomics and Personalized Medicine. Volume 14. 893–903. 5 indexed citations
8.
Droppa, Michal, Tanja K. Rudolph, Jan Baan, et al.. (2020). Risk factors for permanent pacemaker implantation in patients receiving a balloon-expandable transcatheter aortic valve prosthesis. Heart and Vessels. 35(12). 1735–1745. 6 indexed citations
10.
Droppa, Michal, Muthiah Vaduganathan, Ramkumar Venkateswaran, et al.. (2019). Cangrelor in cardiogenic shock and after cardiopulmonary resuscitation: A global, multicenter, matched pair analysis with oral P2Y12 inhibition from the IABP-SHOCK II trial. Resuscitation. 137. 205–212. 44 indexed citations
11.
Droppa, Michal, Oliver Borst, Peter Bramlage, et al.. (2018). Clinical and economical impact of the presence of an extended heart team throughout the balloon-expandable transcatheter aortic valve implantation procedure. Clinical Research in Cardiology. 108(3). 315–323. 3 indexed citations
12.
Patzelt, Johannes, Karin Müller, Michal Droppa, et al.. (2018). Previous TAVR in patients undergoing percutaneous edge-to-edge mitral valve repair (PMVR) affects improvement of MR. PLoS ONE. 13(10). e0205930–e0205930. 9 indexed citations
13.
Rath, Dominik, Madhumita Chatterjee, Patrick Krumm, et al.. (2018). Relative survival potential of platelets is associated with platelet CXCR4/CXCR7 surface exposure and functional recovery following STEMI. Atherosclerosis. 278. 269–277. 16 indexed citations
14.
Geisler, Tobias, Michal Droppa, Karin Müller, & Oliver Borst. (2018). Antithrombotic Therapy After TAVR. Current Vascular Pharmacology. 16(5). 437–445. 1 indexed citations
15.
Patzelt, Johannes, Yingying Zhang, Harry Magunia, et al.. (2017). Immediate increase of cardiac output after percutaneous mitral valve repair (PMVR) determined by echocardiographic and invasive parameters. International Journal of Cardiology. 236. 356–362. 11 indexed citations
16.
Droppa, Michal, Oliver Borst, Dominik Rath, et al.. (2017). Impact of Intravenous P2Y12-Receptor Inhibition with Cangrelor in Patients Presenting with Acute Coronary Syndrome and Cardiogenic Shock – a Case Series. Cellular Physiology and Biochemistry. 42(4). 1336–1341. 10 indexed citations
17.
Rath, Dominik, Elke Schaeffeler, Stefan Winter, et al.. (2016). SDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease. PLoS ONE. 11(9). e0161933–e0161933. 9 indexed citations
18.
Droppa, Michal, Karin Müller, Athanasios Karathanos, et al.. (2015). Evaluation of Clinical Risk Factors to Predict High On-Treatment Platelet Reactivity and Outcome in Patients with Stable Coronary Artery Disease (PREDICT-STABLE). PLoS ONE. 10(3). e0121620–e0121620. 31 indexed citations
19.
Rath, Dominik, Madhumita Chatterjee, Iris Müller, et al.. (2014). Platelet expression of transforming growth factor beta 1 is enhanced and associated with cardiovascular prognosis in patients with acute coronary syndrome. Atherosclerosis. 237(2). 754–759. 26 indexed citations
20.
Droppa, Michal, Steffen Desch, Ingo Eitel, et al.. (2011). Impact of N-acetylcysteine on contrast-induced nephropathy defined by cystatin C in patients with ST-elevation myocardial infarction undergoing primary angioplasty. Clinical Research in Cardiology. 100(11). 1037–1043. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026